PUBLISHER: Grand View Research | PRODUCT CODE: 1751412
PUBLISHER: Grand View Research | PRODUCT CODE: 1751412
The global cold plasma technology market is anticipated to reach USD 3,466.2 million by 2030 and is expected to grow at a CAGR of 6.3% during the forecast period, according to a new report by Grand View Research, Inc. The global cold plasma technology market is witnessing significant growth driven by advancements in electronics manufacturing, as there is a growing demand for precise, contamination-free surface treatments. In semiconductor and microelectronics production, where components are tiny and delicate, cold plasma provides non-thermal, highly controlled surface cleaning, activation, etching, ensuring strong adhesion, accurate patterning, and defect-free fabrication.
Market opportunities in the cold plasma technology market is miniaturization of components, especially in the automotive industry. As components become smaller, the demand for portable, scalable cold plasma systems increases. These systems allow for precise, on-site surface treatments, enhancing efficiency, lowering production costs, and providing greater flexibility for manufacturers without requiring large-scale setups.
Regulatory pressures are crucial in shaping the cold plasma technology market by enforcing standards that drive innovation and compliance. Organizations like ASTM and ISO set critical standards for cold plasma technology equipment. ASTM provides guidelines for measuring adhesion strength and performance, while ISO sets global benchmarks for quality, safety, and efficiency, ensuring the technology meets industry requirements and operates reliably across various applications.
Top players in the cold plasma technology market, such as Plasmatreat and relyon plasma GmbH, are focusing on innovation and expanding their product offerings to cater to different industries. Companies are prioritizing collaborations with various industries to expand applications. Strategic partnerships and acquisitions are common to increase market share and innovation. For instance, in May 2024, Plasmalex, formed by the merger of Europlasma and CPI, expanded its portfolio by acquiring Switzerland-based COAT-X SA. COAT-X specializes in implantable multilayer thin films, offering advanced parylene, ALD, and multilayer barrier solutions. This acquisition enhances Plasmalex's capabilities in surface functionalization and protection, particularly for medical, electronics, and micromechanics applications.